Azelis Group NV

ENXTBR:AZE Lagerbericht

Marktkapitalisierung: €2.8b

Azelis Group Vergangene Ertragsentwicklung

Vergangenheit Kriterienprüfungen 2/6

Azelis Group verzeichnete einen durchschnittlichen jährlichen Gewinnzuwachs von 11.1%, während die Gewinne der Branche Trade Distributors jährlich um gewachsen und zwar um 3.1%. Die Umsätze verzeichneten einen durchschnittlichen jährlichen Gewinnzuwachs von gewachsen von 11.1%. Die Eigenkapitalrendite von Azelis Group beträgt 4.2% und die Nettomargen betragen 2.7%.

Wichtige Informationen

11.11%

Wachstumsrate der Gewinne

17.79%

EPS-Wachstumsrate

Trade Distributors Wachstum der Industrie18.43%
Wachstumsrate der Einnahmen11.08%
Eigenkapitalrendite4.18%
Netto-Marge2.70%
Nächste Ertragsaktualisierung30 Jul 2026

Jüngste Aktualisierungen vergangener Leistungen

Recent updates

AZE: Governance Changes And Share Buybacks Will Pressure Premium P/E Expectations

Azelis Group's analyst price targets have shifted to a range between €10.50 and €15, reflecting updated views on fair value, discount rates, revenue growth and profit margins as analysts recalibrate expectations for the stock. Analyst Commentary Recent price target revisions for Azelis Group sit between €10.50 and €15, with some bearish analysts trimming expectations and others only making modest upward adjustments.

AZE: Downgrades And Governance Changes Will Pressure Premium P/E Expectations

Analysts have nudged the fair value estimate for Azelis Group higher to €7.60 from €7.50, citing updated assumptions on revenue growth and discount rates, along with mixed changes in Street price targets that now range from €10.50 to €15. Analyst Commentary Recent research shows a split view on Azelis Group, with some Bearish analysts trimming expectations while others take a more neutral stance.

AZE: Dividend Clarity And Refined Assumptions Will Support A More Constructive Outlook

The updated analyst price target for Azelis Group moves slightly lower to about €17.35 from roughly €17.70. Analysts point to refined assumptions on discount rates, revenue growth, profit margins and future P/E to support the change.

AZE: Higher Dividend Visibility Will Support A More Constructive Outlook

The analyst price target for Azelis Group has been reduced from about €24.00 to roughly €17.70, as analysts factor in updated assumptions for discount rates, revenue growth, profit margins and future P/E, along with recent mixed Street research where some firms trimmed targets while others made only modest upward adjustments. Analyst Commentary Street research on Azelis Group has been mixed, but there are pockets of optimism that stand out in the recent updates.

AZE: Margin Recovery And Dividend Visibility Will Support Future Upside Potential

Azelis Group’s analyst fair value estimate has been trimmed from €13.20 to about €12.48. This reflects a reset in price targets after some analysts reduced their outlooks toward the mid-teens and low double digits, while still factoring in updated views on growth, margins and future P/E levels.

AZE: Margin Recovery Will Support Upside Despite Recent Discounted Reset

Analysts have trimmed their price target for Azelis Group from about €14.27 to €13.20, citing updated assumptions for fair value, discount rate, revenue growth, profit margin and future P/E multiples following recent research, including the latest Kepler Cheuvreux downgrade. Analyst Commentary Recent research points to a more cautious stance on Azelis Group, with the latest price target reset to about €13.20.

AZE: Downgrades And Sector Headwinds Will Pressure Premium P/E Expectations

Azelis Group’s analyst price target has shifted lower to about €7.50 from €10.00 as analysts factor in a higher discount rate, more cautious revenue growth assumptions, a lower future P/E multiple, and only a modest adjustment to profit margin expectations following recent downgrades. Analyst Commentary Bearish analysts are resetting expectations around Azelis Group, with several research notes pointing to a more cautious stance on the shares.

AZE: Margin Recovery Is Expected To Support Re-Rating Despite Sector Caution

Narrative update Analysts have trimmed their price target for Azelis Group from about €15.71 to roughly €14.27, reflecting more cautious assumptions on growth, margins and future P/E following a series of rating and target cuts from European brokers. Analyst Commentary Recent research updates on Azelis Group have generally moved in a more cautious direction, with multiple firms lowering ratings and price targets.

AZE: Fair View Balances Sector Headwinds With Prospects For 2025 Margin Recovery

We are lowering our Azelis Group fair value estimate to €10 from €16, reflecting analysts' reduced price targets and more cautious assumptions on growth, margins and sector conditions. Analyst Commentary Recent Street research on Azelis Group has turned more cautious, with several bearish analysts revising ratings and trimming price targets.

AZE: Margins Are Expected To Recover As Industry Pressures Gradually Ease

The analyst price target for Azelis Group has been trimmed slightly to EUR 15.71 from EUR 15.82 as analysts factor in softer revenue growth and margins amid ongoing industry headwinds, partially offset by expectations for a gradual recovery and resilient valuation multiples. Analyst Commentary Analyst sentiment on Azelis Group has become more mixed, with a growing divergence between those who see the current downturn as an attractive entry point and those who expect industry headwinds to constrain performance for longer.

AZE: Demand And Margins Will Recover From Current Cyclical Weakness

Azelis Group's analyst price target has been trimmed from about EUR 16.25 to approximately EUR 15.82, as analysts factor in sector wide pressure on European chemicals, more cautious views on diversified distributors, and expectations for only gradual recovery in growth and margins despite some supportive initiation coverage. Analyst Commentary Recent Street research on Azelis reflects a mixed backdrop, with several downward rating and target revisions offset by selective bullish initiation.

AZE: Demand And Margins Will Rebound From Trough In 2025

Azelis Group’s analyst fair value target has been lowered from €17.39 to €16.25. Analysts point to ongoing industry headwinds and recent sector downgrades as key drivers of the more cautious outlook.

Investor Optimism Abounds Azelis Group NV (EBR:AZE) But Growth Is Lacking

Nov 14
Investor Optimism Abounds Azelis Group NV (EBR:AZE) But Growth Is Lacking

AZE: Earnings Momentum Will Strengthen As Industry Conditions Improve In 2025

Azelis Group's analyst price target was revised downward by EUR 0.50 to EUR 17.39. This reflects analysts' expectations of slower revenue growth and persistent margin pressures in the near term.

Recovery Will Likely Emerge After Industry Pressures Ease In 2026

The analyst price target for Azelis Group has decreased from €18.50 to €17.89. This change reflects cautious sentiment among analysts amid industry headwinds and anticipated margin pressures through mid-2026.

Life Sciences Recovery And Digitalization Investments Will Improve Future Efficiency

Azelis Group's analyst price target has been reduced from €19.13 to €18.50. Analysts cite ongoing industry headwinds and reduced earnings forecasts as reasons for the cautious outlook.

Here's Why Azelis Group (EBR:AZE) Has A Meaningful Debt Burden

Sep 30
Here's Why Azelis Group (EBR:AZE) Has A Meaningful Debt Burden

Life Sciences Recovery And Digitalization Investments Will Improve Future Efficiency

Analysts have trimmed Azelis Group’s price target to €19.13, citing weaker Q2 earnings, a more conservative sector outlook, and increased market risk, partially offset by sustained strength in specialty testing. Analyst Commentary Reduced earnings estimates following a weaker-than-expected Q2 report.

Life Sciences Recovery And Digitalization Investments Will Improve Future Efficiency

Analysts have trimmed their earnings estimates and near-term growth outlook for Azelis Group amid sector challenges and softer fundamentals, resulting in a stable consensus price target of €19.56. Analyst Commentary Reduced earnings estimates following a weaker-than-expected Q2 report.

Azelis Group (EBR:AZE) Is Experiencing Growth In Returns On Capital

Jul 13
Azelis Group (EBR:AZE) Is Experiencing Growth In Returns On Capital

Unpleasant Surprises Could Be In Store For Azelis Group NV's (EBR:AZE) Shares

Jun 17
Unpleasant Surprises Could Be In Store For Azelis Group NV's (EBR:AZE) Shares

Azelis Group's (EBR:AZE) Dividend Will Be Increased To €0.161

May 30
Azelis Group's (EBR:AZE) Dividend Will Be Increased To €0.161

An Intrinsic Calculation For Azelis Group NV (EBR:AZE) Suggests It's 39% Undervalued

May 27
An Intrinsic Calculation For Azelis Group NV (EBR:AZE) Suggests It's 39% Undervalued

Azelis Group's (EBR:AZE) Shareholders Will Receive A Bigger Dividend Than Last Year

May 09
Azelis Group's (EBR:AZE) Shareholders Will Receive A Bigger Dividend Than Last Year

Azelis Group (EBR:AZE) Is Paying Out A Larger Dividend Than Last Year

Apr 25
Azelis Group (EBR:AZE) Is Paying Out A Larger Dividend Than Last Year

Azelis Group (EBR:AZE) Shareholders Will Want The ROCE Trajectory To Continue

Mar 28
Azelis Group (EBR:AZE) Shareholders Will Want The ROCE Trajectory To Continue

Azelis Group NV Just Missed EPS By 11%: Here's What Analysts Think Will Happen Next

Mar 10
Azelis Group NV Just Missed EPS By 11%: Here's What Analysts Think Will Happen Next
User avatar

Life Sciences Recovery And Digitalization Investments Will Improve Future Efficiency

Strategic acquisitions and a strong M&A pipeline suggest future revenue growth and expanded net margins from realized synergies.

Is Azelis Group (EBR:AZE) Using Too Much Debt?

Feb 23
Is Azelis Group (EBR:AZE) Using Too Much Debt?

Are Investors Undervaluing Azelis Group NV (EBR:AZE) By 35%?

Jan 27
Are Investors Undervaluing Azelis Group NV (EBR:AZE) By 35%?

Azelis Group NV's (EBR:AZE) Earnings Haven't Escaped The Attention Of Investors

Jan 06
Azelis Group NV's (EBR:AZE) Earnings Haven't Escaped The Attention Of Investors

There's Been No Shortage Of Growth Recently For Azelis Group's (EBR:AZE) Returns On Capital

Nov 23
There's Been No Shortage Of Growth Recently For Azelis Group's (EBR:AZE) Returns On Capital

Azelis Group (EBR:AZE) Seems To Use Debt Quite Sensibly

Oct 18
Azelis Group (EBR:AZE) Seems To Use Debt Quite Sensibly

With Azelis Group NV (EBR:AZE) It Looks Like You'll Get What You Pay For

Sep 30
With Azelis Group NV (EBR:AZE) It Looks Like You'll Get What You Pay For

Azelis Group NV's (EBR:AZE) Intrinsic Value Is Potentially 50% Above Its Share Price

Aug 24
Azelis Group NV's (EBR:AZE) Intrinsic Value Is Potentially 50% Above Its Share Price

Azelis Group NV Just Missed EPS By 28%: Here's What Analysts Think Will Happen Next

Aug 04
Azelis Group NV Just Missed EPS By 28%: Here's What Analysts Think Will Happen Next

We Like These Underlying Return On Capital Trends At Azelis Group (EBR:AZE)

Jul 26
We Like These Underlying Return On Capital Trends At Azelis Group (EBR:AZE)

Azelis Group (EBR:AZE) Will Pay A Smaller Dividend Than Last Year

Jun 14
Azelis Group (EBR:AZE) Will Pay A Smaller Dividend Than Last Year

Here's Why Azelis Group (EBR:AZE) Can Manage Its Debt Responsibly

Jun 09
Here's Why Azelis Group (EBR:AZE) Can Manage Its Debt Responsibly

Azelis Group's (EBR:AZE) Dividend Is Being Reduced To €0.154

May 22
Azelis Group's (EBR:AZE) Dividend Is Being Reduced To €0.154

Calculating The Intrinsic Value Of Azelis Group NV (EBR:AZE)

Apr 22
Calculating The Intrinsic Value Of Azelis Group NV (EBR:AZE)

Investor Optimism Abounds Azelis Group NV (EBR:AZE) But Growth Is Lacking

Apr 04
Investor Optimism Abounds Azelis Group NV (EBR:AZE) But Growth Is Lacking

Azelis Group's (EBR:AZE) Dividend Will Be Reduced To €0.154

Mar 13
Azelis Group's (EBR:AZE) Dividend Will Be Reduced To €0.154

Azelis Group (EBR:AZE) Is Doing The Right Things To Multiply Its Share Price

Jan 11
Azelis Group (EBR:AZE) Is Doing The Right Things To Multiply Its Share Price

Azelis Group NV (EBR:AZE) Shares Could Be 34% Below Their Intrinsic Value Estimate

Nov 24
Azelis Group NV (EBR:AZE) Shares Could Be 34% Below Their Intrinsic Value Estimate

Aufschlüsselung der Einnahmen und Ausgaben

Wie Azelis Group Geld verdient und ausgibt. Basierend auf den neuesten gemeldeten Einnahmen der letzten zwölf Monate.


Gewinn- und Umsatzhistorie

ENXTBR:AZE Einnahmen, Ausgaben und Erträge (EUR Millions)
DatumEinnahmenGewinnAllgemeine und VerwaltungskostenF&E-Ausgaben
31 Dec 254,1111115260
30 Sep 254,1691405320
30 Jun 254,2271695380
31 Mar 254,2211755320
31 Dec 244,2141815270
30 Sep 244,1851755150
30 Jun 244,1571695040
31 Mar 244,1541734970
31 Dec 234,1521784900
30 Sep 234,1921784880
30 Jun 234,2311784860
31 Mar 234,1701964820
31 Dec 224,1092134790
30 Sep 223,8231874580
30 Jun 223,5371604370
31 Mar 223,1821144010
31 Dec 212,827683660
30 Sep 212,613793340
30 Jun 212,398903030
31 Mar 212,310802940
31 Dec 202,223712860
31 Dec 192,095482700
31 Dec 18616-521440

Qualität der Erträge: AZE hat hohe Qualitätseinkünfte.

Wachsende Gewinnspanne: AZEDie aktuellen Gewinnspannen (2.7%) sind niedriger als im letzten Jahr (4.3%).


Analyse von freiem Cashflow und Gewinn


Analyse des Gewinnwachstums in der Vergangenheit

Ergebnisentwicklung: AZEIn den letzten 5 Jahren sind die Gewinne von 11.1% jährlich gestiegen.

Beschleunigtes Wachstum: AZEDas Unternehmen hat im vergangenen Jahr ein negatives Gewinnwachstum verzeichnet, so dass es nicht mit seinem 5-Jahres-Durchschnitt verglichen werden kann.

Erträge im Vergleich zur Industrie: AZE hatte im vergangenen Jahr ein negatives Gewinnwachstum (-38.5%), was einen Vergleich mit dem Branchendurchschnitt Trade Distributors (0.8%) erschwert.


Eigenkapitalrendite

Hohe Eigenkapitalrendite: AZEDie Eigenkapitalrendite des Unternehmens (4.2%) wird als niedrig angesehen.


Kapitalrendite


Rendite auf das eingesetzte Kapital


Entdecken Sie starke Unternehmen, die in der Vergangenheit erfolgreich waren

Unternehmensanalyse und Finanzdaten Status

DatenZuletzt aktualisiert (UTC-Zeit)
Unternehmensanalyse2026/05/04 14:21
Aktienkurs zum Tagesende2026/05/04 00:00
Gewinne2025/12/31
Jährliche Einnahmen2025/12/31

Datenquellen

Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.

PaketDatenZeitrahmenBeispiel US-Quelle *
Finanzdaten des Unternehmens10 Jahre
  • Gewinn- und Verlustrechnung
  • Kapitalflussrechnung
  • Bilanz
Konsensschätzungen der Analysten+3 Jahre
  • Finanzielle Vorausschau
  • Kursziele der Analysten
Marktpreise30 Jahre
  • Aktienkurse
  • Dividenden, Splits und Aktionen
Eigentümerschaft10 Jahre
  • Top-Aktionäre
  • Insiderhandel
Verwaltung10 Jahre
  • Das Führungsteam
  • Direktorium
Wichtige Entwicklungen10 Jahre
  • Ankündigungen des Unternehmens

* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige regulatorische Formulare und Quellen verwendet.

Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie mehr.

Analysemodell und Schneeflocke

Einzelheiten zu dem Analysemodell, mit dem dieser Bericht erstellt wurde, finden Sie auf unserer Github-Seite. Außerdem bieten wir Leitfäden zur Verwendung unserer Berichte und Tutorials auf YouTube an.

Erfahren Sie mehr über das Weltklasse-Team, das das Simply Wall St-Analysemodell entworfen und entwickelt hat.

Metriken für Industrie und Sektor

Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf Github.

Analysten-Quellen

Azelis Group NV wird von 21 Analysten beobachtet. 12 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.

AnalystEinrichtung
Gaurav JainBarclays
James StewartBarclays
Anil ShenoyBarclays